Home › NDC Lookup › Ingredients › Guaifenesin Dextromethorphan Hbr › 00536-1161-34
Mucus Relief DM Extended Release Caplets Guaifenesin, Dextromethorphan HBr 600 mg; 30 mg Tablet, Extended Release, 20-count — NDC 00536-1161-34 package photo

Mucus Relief DM Extended Release Caplets Guaifenesin, Dextromethorphan HBr 600 mg; 30 mg Tablet, Extended Release, 20-count

by Rugby Laboratories · 20 BLISTER PACK in 1 CARTON (0536-1161-34) / 1 TABLET in 1 BLISTER PACK
NDC 00536-1161-34
🏷️ FDA NDC (as labeled) 0536-1161-34 billing pads the labeler segment with a zero
This package
Contains20-count Cost per ea$0.3560 NADAC Per package$7.12 / 20 tablet Pack sizes2 compare ↓
Also priced by: Medicaid pays $0.7066/unit — full pricing hub ↓
Also comes in: 40 tablets 00536-1161-37
OTC Generic On market Non-controlled
🗂️ Data synced Sep 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 0536-1161-34
Product NDC 0536-1161
11-digit billing NDC 00536116134
NCPDP billing unit EA — each (per item)
RxCUI 1298324
UNII 495W7451VQ, 9D2RTI9KYH
UPC 0305361161378
Application # ANDA209692
SPL Set ID 69cd399a-0103-4543-bb06-c7cccffe9cc4
Established class (EPC) Expectorant
Physiologic effect Decreased Respiratory Secretion Viscosity; Increased Respiratory Secretions
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2018-12-13
Route ORAL
Dosage form TABLET, EXTENDED RELEASE
Substance GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE
GPI-14 43997002527430
GPI class Mucus Relief DM
GCN Seq No 012074
GCN 53550
HICL code 000223
Ingredient (HICL) Guaifenesin/Dextromethorphan
HIC1 code B
Therapeutic class — broad (HIC1) Respiratory System
HIC2 code B3
Therapeutic class — intermediate (HIC2) Drugs Affecting Primarily The Trachea And Bronchi
HIC3 code B3T
Therapeutic class — specific (HIC3) Non-Opioid Antitussive And Expectorant Combination
AHFS code 48:08.00.00
AHFS class Antitussives
FDB label name MUCUS RLF DM ER 600-30 MG TAB
FDB brand name Mucus Relief Dm Er
Legend status O — Over-the-counter (OTC) drug or device
Why two NDCs? The FDA registers this code as 0536-1161-34 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00536-1161-34. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Uncompetitive N-methyl-D-aspartate Receptor Antagonist class.

Pharmacologic class Uncompetitive N-methyl-D-aspartate Receptor Antagonist, Sigma-1 Agonist
Drug family (ATC) Other antidepressants, Opium alkaloids and derivatives
How it works Uncompetitive NMDA Receptor Antagonists, Sigma-1 Receptor Agonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerRugby Laboratories
Application holderAMNEAL PHARMACEUTICALS OF NEW YORK LLC
FDA applicationANDA209692 (ANDA)
Labeler code00536
First marketedDec 2018
Product typeHuman Otc Drug
Portfolio149 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name MUCUS RLF DM ER 600-30 MG TAB Ingredient Guaifenesin/Dextromethorphan
📖 What it is MedlinePlus · NLM

Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • The two ingredients tackle your symptoms from different angles. Guaifenesin is an expectorant — it helps thin and loosen the mucus in your chest so you can cough it up more easily....
  • What exactly does this combination do — why are two ingredients needed?
  • It depends on which antidepressant you're taking. If it's a type called an MAOI — which includes certain older antidepressants and some medications for Parkinson's disease — you sh...
  • Can I take this if I'm on an antidepressant?
📖 Read our full Dextromethorphan / Guaifenesin guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color yellow
ShapeOval
ImprintAN038
Size16 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII Z135WT9208
    Carbomer is a synthetic polymer that forms a thick, gel-like consistency. It's used in medicines as a thickener and stabilizer to improve texture and keep ingredients evenly mixed throughout the product.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII 35SW5USQ3G
    A synthetic yellow dye used to color medicines. It helps make tablets, capsules, and liquids visually distinct so patients can easily identify their medication.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII EWQ57Q8I5X
    Lactose monohydrate is a natural sugar derived from milk. It serves as a filler and binder in tablets and capsules, helping create the proper size, texture, and consistency of the medicine.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII FZ989GH94E
    Povidone is a synthetic polymer made from a plastic-like material. It acts as a binder to hold tablet ingredients together and as a disintegrant to help the tablet break apart in your stomach so the medicine can be absorbed.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII 7SEV7J4R1U
    A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.

9 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescarbomer, colloidal silicon dioxide, D&Cyellow #10 aluminum lake, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, povidone, talc

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.356 $7.12 / 20 tablet
Medicaid paysCMS SDUD · 12 mo $0.7066 $14.13 / 20 tablet
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Jan 2022 Aug 2022 Jan 2026 Sep 2026 $0.495 $0.348
▼ Down 19% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Mucus Relief DM Extended Release Caplets 600 mg/1; 30 mgthis 00536-1161-34 Rugby 20 tablets $0.356 — Availability likely —
Rugby Mucus Relief DM ER 30 mg/1; 600 mg 00536-1446-34 Rugby 20 tablets $0.356 — Availability likely —
Good Neighbor Pharmacy Mucus Dm 30 mg/1; 600 mg 46122-0817-61 Amerisource 20 tablets $0.356 — Availability likely —
Leader Mucus Relief DM 30 mg/1; 600 mg 70000-0722-01 Cardinal 20 tablets $0.356 — Availability likely —
Mucus Relief DM 600 mg/1; 30 mg 70677-1050-01 Strategic 1 tablet $0.356 — Availability likely —
Mucus Relief DM 600 mg/1; 30 mg 70000-0491-01 CARDINAL 20 tablets $0.359 — Discontinued +1%
Mucinex DM 600 mg/1; 30 mg 63824-0056-01 Reckitt 20 tablets $0.608 — Discontinued +71%
Good Sense Mucus DM 30 mg/1; 600 mg 00113-2219-01 L. 20 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 00363-0474-01 WALGREEN 10 tablets — — FDA listed —
Mucus Relief DM Extended Release Caplets 600 mg/1; 30 mg 00363-0733-20 Walgreens 20 tablets — — FDA listed —
Mucus Relief DM 30 mg/1; 600 mg 00363-3219-01 Walgreen 20 tablets — — FDA listed —
up and up mucus relief dm 30 mg/1; 600 mg 11673-0716-01 Target 20 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 11822-0733-02 Rite 20 tablets — — FDA listed —
mucus relief DM 30 mg/1; 600 mg 11822-2219-00 Rite 20 tablets — — FDA listed —
Mucus Relief DM Extended Release Caplets 600 mg/1; 30 mg 17856-1162-01 ATLANTIC 1 tablet — — FDA listed —
Mucus Relief Dm 600 mg/1; 30 mg 21130-0997-67 Better 10 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 30142-0276-20 KROGER 10 tablets — — FDA listed —
Guaifenesin And Dextromethorphan Hbr 600 mg/1; 30 mg 30142-0948-20 Kroger 20 tablets — — FDA listed —
Topcare Mucus DM 30 mg/1; 600 mg 36800-0219-01 Topco 20 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 37808-0733-40 H 40 tablets — — FDA listed —
equaline mucus dm 30 mg/1; 600 mg 41163-0599-01 United 20 tablets — — FDA listed —
mucus relief dm 30 mg/1; 600 mg 41250-0436-01 Meijer 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 41415-0998-20 PUBLIX 20 tablets — — FDA listed —
Mucus Dm 30 mg/1; 600 mg 42507-0222-20 HyVee 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBR 600 mg/1; 30 mg 43598-0114-01 Dr. 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBR 600 mg/1; 30 mg 43598-0231-01 Dr. 20 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 49035-0960-12 Wal-Mart 40 tablets — — FDA listed —
Mucinex Dm 600 mg/1; 30 mg 50090-1077-00 A-S 20 tablets — — FDA listed —
Mucinex DM 600 mg/1; 30 mg 50090-1078-00 A-S 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBR 600 mg/1; 30 mg 51316-0009-01 CVS 20 tablets — — FDA listed —
Cough And Congestion Extended Release 600 mg/1; 30 mg 51316-0065-67 CVS 10 tablets — — FDA listed —
Mucus Relief Dm 30 mg/1; 600 mg 51316-0858-78 CVS 100 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 51660-0301-21 OHM 20 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 55910-0733-06 Dolgencorp, 6 tablets — — FDA listed —
DG health mucus dm 30 mg/1; 600 mg 55910-0746-01 Dolgencorp 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 58602-0714-05 Aurohealth 14 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 58602-0824-08 Aurohealth 10 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 58602-0871-83 Aurohealth 10 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 59726-0733-06 P 6 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 60000-0058-67 Ahold 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 63304-0106-21 SUN 20 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 63941-0733-20 Best 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 65162-0038-03 Amneal 30 tablets — — FDA listed —
Mucinex DM, TRAVEL BASIX 600 mg/1; 30 mg 66715-6424-01 Lil' 2 tablets — — FDA listed —
Mucinex DM, CVP HEALTH 600 mg/1; 30 mg 66715-6524-01 Lil' 2 tablets — — FDA listed —
Mucinex DM 600 mg/1; 30 mg 66715-9724-01 Lil' 2 tablets — — FDA listed —
Mucus Relief DM Expectorant and Cough Suppressant 600 mg/1; 30 mg 67091-0314-20 Winco 10 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 67091-0344-20 WinCo 20 tablets — — FDA listed —
Mucinex DM 30 mg/1; 600 mg 67751-0171-01 Navajo 2 tablets — — FDA listed —
Mucus DM Extended Release 600 mg/1; 30 mg 69842-0057-11 CVS 10 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 69842-0933-20 CVS 20 tablets — — Discontinued —
mucus dm extended release 30 mg/1; 600 mg 69842-0963-01 CVS 20 tablets — — FDA listed —
Mucus Relief Dm 600 mg/1; 30 mg 72036-0012-20 Harris 10 tablets — — FDA listed —
basic care mucus dm 30 mg/1; 600 mg 72288-0219-49 Amazon.com 40 tablets — — FDA listed —
Amazon Basic Care Mucus Dm 600 mg/1; 30 mg 72288-0220-08 Amazon.com 10 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 72476-0733-20 Care 20 tablets — — FDA listed —
equate mucus relief dm 30 mg/1; 600 mg 79903-0065-01 WALMART 20 tablets — — FDA listed —
Mucinex DM 600 mg/1; 30 mg 85237-1650-01 Select 2 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 85766-0150-14 Sportpharm 14 tablets — — FDA listed —
Good Sense Mucus DM 30 mg/1; 600 mg 85766-0172-20 Sportpharm 20 tablets — — FDA listed —
Mucinex DM 600 mg/1; 30 mg 85766-0176-20 Sportpharm 20 tablets — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2018
On the market since
Dec 2018
📍
2026
Currently FDA-listed
8 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 00536-1161-34, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
20.3K
Units reimbursed last 4 qtrs
597.3K
Gross reimbursed last 4 qtrs
$422K
Avg / prescription
$20.77
Avg / unit
$0.7066
Latest quarter Q1 2026
1.7KRx
Medicaid pays / ea
$0.7066
gross reimbursed
vs
NADAC / ea
$0.3560
acquisition cost
=
Spread
+$0.3506
+98% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
63% FFS 37% MCO
Fee-for-service · 12,790 Rx Managed care · 7,533 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 5,649 units · 98.5 per 100k residents MN Wisconsin: no data reported WI Michigan: 1,505 units · 15.0 per 100k residents MI New York: 394,904 units · 2,018 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: 614 units · 19.2 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: 6,237 units · 90.9 per 100k residents IN Ohio: 47,191 units · 400 per 100k residents OH Pennsylvania: 39,624 units · 306 per 100k residents PA New Jersey: 3,548 units · 38.2 per 100k residents NJ Massachusetts: no data reported MA California: 582 units · 1.5 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 6,047 units · 306 per 100k residents NE Missouri: no data reported MO Kentucky: 37,862 units · 837 per 100k residents KY West Virginia: 634 units · 35.8 per 100k residents WV Virginia: 6,878 units · 78.9 per 100k residents VA Maryland: 1,898 units · 30.7 per 100k residents MD Connecticut: no data reported CT Rhode Island: 1,272 units · 116 per 100k residents RI Arizona: 7,839 units · 105 per 100k residents AZ New Mexico: 508 units · 24.0 per 100k residents NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: 1,334 units · 24.8 per 100k residents SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: 12,777 units · 116 per 100k residents GA D.C.: no data reported DC Hawaii: 1,296 units · 90.3 per 100k residents HI Texas: 19,101 units · 62.6 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
1.52,018
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 New York 2,018 /100k
2 Kentucky 837 /100k
3 Ohio 400 /100k
4 Pennsylvania 306 /100k
5 Nebraska 306 /100k
6 Rhode Island 116 /100k
7 Georgia 116 /100k
8 Arizona 105 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

💊 Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
40 tablets00536-1161-37 63,233 Rx · $1,450,272
20 tablets this page00536-1161-34 20,323 Rx · $422,028
Drug total (last 4 qtrs): 83,556 Rx · 2,785,793 units · $1,872,300 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Mucus Relief DM Extended Release Caplets (this brand).

Top reported reactions

Circumstance Or Information Capable Of Leading To Medication Error1
Product Label Confusion1
Product Lot Number Issue1

Reporter sex

1 reports
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startStatus
00536-1161-34 You're viewing this 20 BLISTER PACK in 1 CARTON (0536-1161-34) / 1 TABLET in 1 BLISTER PACK $0.3560 / ea $7.12 2018-12-13 Active
00536-1161-37 40 BLISTER PACK in 1 CARTON (0536-1161-37) / 1 TABLET in 1 BLISTER PACK $0.3560 / ea $14.24 2018-12-13 Active

This pack has the lowest per-ea cost of the 2 priced pack sizes ($0.3560 NADAC).

This pack accounts for about 24% of this product's recent Medicaid fills; most go to a different pack size. See all packs ↓

Pack size FAQ

What quantity is in NDC 00536-1161-34?
NDC 00536-1161-34 is a 20-count package — 20 blister pack in 1 carton / 1 tablet in 1 blister pack.
What is the difference between NDC 00536-1161-34 and NDC 00536-1161-37?
Both are Mucus Relief DM Extended Release Caplets Guaifenesin, Dextromethorphan HBr 600 mg; 30 mg Tablet, Extended Release — the drug itself is identical. NDC 00536-1161-34 is the 20-count package, while NDC 00536-1161-37 is the 40 tablets package.
What NDC number is used to bill for this package of Mucus Relief DM Extended Release Caplets Guaifenesin, Dextromethorphan HBr 600 mg; 30 mg Tablet, Extended Release?
Bill NDC 00536-1161-34 — the 11-digit billing format is 00536116134. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 56 words ▾

Uses helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive temporarily relieves cough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritants the intensity of coughing the impulse to cough to help you get to sleep

⏱️ Dosage and Administration 59 words ▾

Directions do not crush, chew, or break tablet take with a full glass of water this product can be administered without regards for timing of meals adults and children 12 years of age and older: 1 or 2 tablet every 12 hours; not more than 4 tablets in 24 hours children under 12 years of age: do not use

⚠️ Warnings 164 words ▾

Warnings Do not use for children under12 years of age if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema cough accompanied by too much phlegm (mucus) When using this product, do not use more than directed.

Stop use and ask a doctor if cough lasts more than 7 days, comes back, or occurs with fever, rash or persistent headache. These could be signs of a serious condition. If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

🧪 Active Ingredient 13 words ▾

Active ingredients (in each extended-release tablet) Dextromethorphan HBr 30 mg Guaifenesin 600 mg

🧪 Inactive Ingredients 19 words ▾

Inactive ingredients carbomer, colloidal silicon dioxide, D&Cyellow #10 aluminum lake, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, povidone, talc

🎯 Purpose 4 words ▾

Purpose Cough Suppressant Expectorant

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 00536-1147-30 · Rugby 00536-1163-61 · Rugby →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.